[Media Releases] KoreaBio is holding BIO Investor Forum (News MP, 5 Nov 2014)
Title: KoreaBio is holding BIO Investor Forum
Publication: News MP / Won-Seok Choi
Date: 5 Nov 2014
URL: link to website (contents in Korean)
Summary
· KoreaBio (Korea Biotechnology Industry Organization), KDB Daewoo Securities, and Bio-Health Investor & Public Relations Association (President: Sejin Park) are jointly holding the 1st BIO Investor Forum on 11 Nov 2014.
· The event features presentations by biotech companies in all phases of the value chain, from early research up to the market, in cancer, infectious diseases, and orphan diseases, and provides an opportunity for investors to interact with biotechnology companies.
· LegoChem will be part of the Cancer session.
· Mr. Sejin Park, President of Bio-Health Investor & Public Relations Association and CFO/SVP of LegoChem Biosciences said that the forum would be the bellwether of life science investing and business creation, and the ongoing exposure to the investor community would be increased.
About LegoChem Biosciences
LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).